1.Comparison of HBV persistent infection mice models by different serotypes of AAVs carrying HBV genomes.
Xinyao ZHU ; Qingzhang ZHOU ; Wenhong TIAN ; Chunguo LIU ; Xiaoyan DONG ; Xiaobing WU ; Changyuan YU
Chinese Journal of Biotechnology 2015;31(12):1764-1772
In recent years, Hepatitis B virus (HBV) persistent infection mouse model with recombinant adeno-associated virus 8 carrying 1.3 copies of HBV genome (rAAV8-1.3HBV) is concerned. We studied and compared the efficacy among HBV persistent infection mice models by other serotypes except AAV8. First, we prepared and purified five viruses: rAAV1-1.3HBV, rAAV2-1.3HBV, rAAV5-1.3HBV, rAAV8-1.3HBV and rAAV9-1.3HBV. Then we injected each virus into 3 C57BL/6J mice with the dose of lx 1011 vg (Viral genome, vg) per mouse. We detected HBsAg and HBeAg in sera by enzyme-linked immunosorbent assay (ELISA) at different time points post injection. We killed mice 8 weeks post injection and took blood and livers for assay. We detected copies of HBV DNA by real-time quantitative PCR in sera and livers. Meantime, we detected HBcAg in the livers of mice by immunohistochemistry and further performed pathology analysis of these livers. The five groups of mice, HBeAg and HBsAg expression sustained 8 weeks in serological detection and HBV DNA was both detected in sera and livers at the time of 8 weeks post injection. HBeAg, HBsAg, HBV DNA copies expression levels in descending order were AAV8>AAV9>AAV1>AAV5>AAV2. HBcAg expression was detected in livers as well. Varied degrees of liver damage were shown in five groups of mice. This study provides more alternative AAV vector species to establish a persistent infection with hepatitis B model.
Animals
;
Dependovirus
;
classification
;
Disease Models, Animal
;
Enzyme-Linked Immunosorbent Assay
;
Genetic Vectors
;
Genome, Viral
;
Hepatitis B
;
virology
;
Hepatitis B Core Antigens
;
metabolism
;
Hepatitis B Surface Antigens
;
blood
;
Hepatitis B e Antigens
;
blood
;
Hepatitis B virus
;
genetics
;
Mice
;
Mice, Inbred C57BL
;
Serogroup
;
Virus Replication
2.Phenytoin induced chorea: a case report and literature review
Shuning DU ; Yang LI ; Xinyao LI ; Yuling TIAN ; Qiuyan WANG
Chinese Journal of Neurology 2023;56(11):1290-1293
Chorea is a rare adverse effect of phenytoin and is common in children, with widely variable clinical presentations. This article reported a case of an elderly woman presented chorea without nystagmus, ataxia, dysarthria and other typical vestibular-cerebellar symptoms, who took compound theophylline and ephedrine contained phenytoin to treat asthma for 1 year. The serum phenytoin concentrations were at toxic levels and chorea disappeared within 3 days after discontinuation of the drug. The clinical features of previously reported cases of phenytoin-induced chorea were also summarized.
3.Gut microbial balance and liver transplantation: alteration, management, and prediction.
Xinyao TIAN ; Zhe YANG ; Fangzhou LUO ; Shusen ZHENG
Frontiers of Medicine 2018;12(2):123-129
Liver transplantation is a conventional treatment for terminal stage liver diseases. However, several complications still hinder the survival rate. Intestinal barrier destruction is widely observed among patients receiving liver transplant and suffering from ischemia-reperfusion or rejection injuries because of the relationship between the intestine and the liver, both in anatomy and function. Importantly, the resulting alteration of gut microbiota aggravates graft dysfunctions during the process. This article reviews the research progress for gut microbial alterations and liver transplantation. Especially, this work also evaluates research on the management of gut microbial alteration and the prediction of possible injuries utilizing microbial alteration during liver transplantation. In addition, we propose possible directions for research on gut microbial alteration during liver transplantation and offer a hypothesis on the utilization of microbial alteration in liver transplantation. The aim is not only to predict perioperative injuries but also to function as a method of treatment or even inhibit the rejection of liver transplantation.
Animals
;
Gastrointestinal Microbiome
;
Graft Rejection
;
prevention & control
;
Humans
;
Intestinal Mucosa
;
physiopathology
;
ultrastructure
;
Liver Transplantation
;
Rats
;
Reperfusion Injury
;
prevention & control
4.Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation.
Junjun JIA ; Xinyao TIAN ; Jianwen JIANG ; Zhigang REN ; Haifeng LU ; Ning HE ; Haiyang XIE ; Lin ZHOU ; Shusen ZHENG
Frontiers of Medicine 2019;13(4):451-460
Understanding the effect of immunosuppressive agents on intestinal microbiota is important to reduce the mortality and morbidity from orthotopic liver transplantation (OLT). We investigated the relationship between the commonly used immunosuppressive agent cyclosporine A (CSA) and the intestinal microbial variation in an OLT model. The rat samples were divided as follows: (1) N group (normal control); (2) I group (isograft LT, Brown Norway [BN] rat to BN); (3) R group (allograft LT, Lewis to BN rat); and (4) CSA group (R group treated with CSA). The intestinal microbiota was assayed by denaturing gradient gel electrophoresis profiles and by using real-time polymerase chain reaction. The liver histopathology and the alanine/aspartate aminotransferase ratio after LT were both ameliorated by CSA. In the CSA group, the numbers of rDNA gene copies of Clostridium cluster I, Clostridium cluster XIV, and Enterobacteriaceae decreased, whereas those of Faecalibacterium prausnitzii increased compared with the R group. Cluster analysis indicated that the samples from the N, I, and CSA groups were clustered, whereas the other clusters contained the samples from the R group. Hence, CSA ameliorates hepatic graft injury and partially restores gut microbiota following LT, and these may benefit hepatic graft rejection.